Released on = April 16, 2006, 11:13 pm

Press Release Author = RNCOS

Industry = Biotech

Press Release Summary = RNCOS Research: (http://www.rncos.com/Report/Biotech14.htm)
India has a strong desire and potential for the world's future source of biotech
appetite. Already several American and European companies are preparing to set up
subsidiaries in the country.

Press Release Body = RNCOS Research: (http://www.rncos.com/Report/Biotech14.htm) In
its biotechnology industry India is a proud contributor of more than $700 million in
annual revenues. With a growth of 40% over the past year, she is second only to
United States in the total number of FDA-approved drug manufacturing plants. The
various factors accounting for India's blossoming biotechnology industry are skilled
laborers, low costs, new patent protections and a pool of patients ready for
clinical trials. Indian companies are ready learners with its good number of
educated scientists.

India therefore stands as a good destination for manufacturers and marketers.
Several European companies and US are prompted to set up their units in this
country. They also contemplate on forming contracts with Indian firms for
drug-development research, clinical trials and research-data analysis.

According to industry experts India is to soon become a powerful player in global
biotechnology and all by its own merit and may even pose a threat to other nations.
To further support this situation, India is already acquiescing to World Trade
Organization (WTO) patent protections. This would enable Indian firms to find a base
in developed markets of US and Europe, which will further encourage companies to
enhance their R&D with the objective of patenting their own high-end products.

In its market research report, "Indian Biotechnology Market Outlook (2006)" RNCOS
specialists believe that although Indian biotechnology has just started to develop
and holds only 1% of the global biotechnology market, it is poised for a favorable
growth with an expected world market share of 10% over the next five years.

The report gives a fair picture of the future Indian biotech market, the initiatives
and policies of central and state governments covering all segments of the market.
Having made an intensive SWOT analysis the report analyzes the sector in terms of
size, demand, and foreign and domestic markets for 2005 while making forecasts till
2010.

Finally the report lists company profiles of 20 major companies in the biotech
industry including Shantha Biotechnics, Biocon, Bharat Biotech, Wockhardt, Serum
Institute of India, Zydus Cadila, and Aventis Pharma.

The report can make useful reading for this sector's technicians, manufacturers and
researchers.

About RNCOS:
RNCOS, formed in 2002, offers Market Research Reports for your business needs and
aims to put an end to your information pursuit. Our expertise in gathering global
business information for industry research, corporate training, growth consulting,
and business consulting, brings reputed companies and firms to us for business
enhancement solutions. We can be your one-stop-shop for Industry research
information and niche market analysis.

To purchase your copy: http://www.rncos.com/Report/Biotech14.htm
For more information about the report please visit www.rncos.com


Web Site = http://www.rncos.com

Contact Details = RNCOS
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial area, Delhi 92
91-11-4214-1229
info@rncos.com